MIR3145

Across TCGA pan-cancer cohorts, MIR3145 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR3145 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher MIR3145 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3145 expression acts as an unfavorable survival marker, although some lineages such as HNSC and READ show a favorable association.

CHOL, HNSC, and READ are the cancer types where MIR3145 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	II,III,IV	0.227	0.777	.005	54	view →
HNSC	OS	Tertile	IV	0.498	0.255	.002	53	view →
READ	OS	Quartile	All	0.904	0.512	.005	46	view →
UCEC	OS	Tertile	IV	0.133	0.754	<.001	36	view →
MESO	DFS	Tertile	IV	0.079	0.414	.004	18	view →
KIRP	DFS	Tertile	II,III,IV	0.111	0.570	.005	18	view →
PRAD	DFS	Tertile	All	0.613	0.793	.017	18	view →
KIRC	OS	Tertile	II,III,IV	0.858	0.760	.024	14	view →
BLCA	DFS	Tertile	III,IV	0.384	0.251	.033	12	view →
UVM	OS	Tertile	All	0.852	0.638	.034	12	view →
STAD	OS	Quartile	II,III,IV	0.350	0.632	.007	10	view →
LUSC	OS	Median	All	0.823	0.744	.023	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MIR3145–CHOL (OS)

Open the CHOL breakdown →